Drug Profile
Cancer vaccine - Millipore Sigma
Alternative Names: Dendritic cell cancer vaccine - Millipore SigmaLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator EMD Millipore
- Developer EMD Millipore; Washington University School of Medicine
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Malignant melanoma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Malignant-melanoma in USA (Parenteral)